Multiplication rate of J774 and RAW cells in relation to the intracellular growth of ITMAP-263 (not showing significant intracellular multiplication in PECs) and LEM3049 (showing r... by Sarah Hendrickx (321143)

Demographic distributions of the patients and significant differences between the training and test datasets. by Kenta Ninomiya (9969368)

Significant clinical features and number of blood transfusions in cases and controls in three trimesters. by Shyamali Thilakarathne (21736055)

Genes and variant counts for pathways significantly associated with familial lymphoid cancer cases. by Sneha Ralli (16016296)

Coefficients of the reduced linear regression model without multicollinearity. by Dania AL-Najjar (11840857)

Subjects:

Flowchart of neural network and linear regression prediction model. by Dania AL-Najjar (11840857)

Subjects:

Coefficients of the reduced linear regression model without multicollinearity. by Dania AL-Najjar (11840857)

Subjects:

Multivariable logistic analysis showing significant indicators and their odds ratios of dengue confirmation in the health facility-based fever surveillance. by Jacqueline Kyungah Lim (10125351)

Linear trends of weekly prescription rates of NVBP varieties. by Chenxuan Zhu (22622476)

Estimation of the coefficients of a generalised linear model of posttraumatic stress symptomatology. by Beatriz Arregui-Gallego (21553735)

Subjects:

Characterization and outcomes of lymphoma cases based on stage (T-zone cases not included). by Heather Wilson-Robles (731578)

Indicators for competitive comparative advantage and their significance. by Linhan Shao (20978182)

Subjects:

Fig 2 - by Dania AL-Najjar (11840857)

Subjects:

Fig 3 - by Dania AL-Najjar (11840857)

Subjects:

Cases based on number of DG allocation units. by Zeeshan Memon Anjum (12413383)

Subjects:

Deterministic result of the base-case analysis. by Sudewi Mukaromah Khoirunnisa (15288505)

“…Efficacy data and baseline characteristics in the base-case analysis were primarily derived from the 11-year results of the HERA trial. …”

Base-case estimated number of patients categorised in different phenotypes and age groups and their base-case cost of management. by Siew Chin Ong (9314213)

Base-case results based on evidence from randomized controlled trials (means and ranges). The comparator is no intervention. by Afschin Gandjour (342184)

Base-case results (deterministic analysis). by Robert Hodgson (2026294)

Base-case results: Probabilistic analysis. by Robert Hodgson (2026294)